Form 4: Elanco CEO Acquires Deferred Stock Units

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 117.887 deferred stock units.

Summary

• Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc. (ELAN), acquired 117.887 Deferred Stock Units (DSUs).
• The transaction date for the acquisition was March 20, 2026.
• Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
• The DSUs were acquired at a price of $23.98 per unit.
• Following this transaction, Mr. Simmons beneficially owns 23,795.2703 Deferred Stock Units.
• These deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with the Executive Deferral and Stock Match Plan.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, primarily due to the alignment of executive incentives with shareholder interests, though it is a routine compensation event rather than a discretionary open-market purchase.

Positives

• The acquisition of deferred stock units by the CEO aligns management's long-term interests with those of shareholders, as the value of these units is tied to the company's stock performance.

Future Outlook

The deferred stock units are designed to settle in cash or shares of common stock following termination of employment or during a specified future year, indicating a long-term retention and incentive mechanism for the executive.

Management Comments

• The transaction itself reflects a management action related to executive compensation, aligning the CEO's future financial interests with the company's stock performance.

Industry Context

StockSavvy.ai notes that insider acquisitions, particularly of deferred equity awards, are a common component of executive compensation packages across various industries. While not a direct open-market purchase, such grants are intended to align management incentives with long-term shareholder value creation.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) as part of executive compensation is a standard practice in publicly traded companies, comparable to equity incentive plans at peers like Zoetis Inc. (ZTS) or IDEXX Laboratories, Inc. (IDXX).
• The structure, where DSUs settle upon employment termination or a future date, is typical for long-term incentive plans aimed at executive retention and performance alignment.

Stakeholder Impact

• Shareholders may view this transaction as a positive indicator of management's commitment and alignment with the company's long-term performance, as the CEO's compensation is further tied to stock value.

Next Steps

• The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

The acquisition of deferred stock units by the CEO is a standard part of executive compensation and does not indicate a significant change in the company's fundamental outlook or immediate prospects. It primarily reflects ongoing management alignment with shareholder interests, which is generally positive but not a catalyst for a change in investment recommendation.

Keywords

Elanco, ELAN, Jeffrey Simmons, Deferred Stock Units, DSU, Insider Transaction, Executive Compensation